JP Morgan Maintains Overweight on Braze, Lowers Price Target to $34

Benzinga Newsdesk www.benzinga.com Negative 75.2%

Neg 75.2% Neu 0% Pos 0%

JP Morgan analyst Alexei Gogolev maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $35 to $34.